Neurotrophic tyrosine kinase gene fusions: another opportunity for targeting in lung cancer. | Lung Cancer Manag;5(1): 1-4, 2016 Apr. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search EVID@Easy

Neurotrophic tyrosine kinase gene fusions: another opportunity for targeting in lung cancer.

Raez, Luis E; Rolfo, Christian.

Affiliation

Raez LE; Memorial Cancer Institute, Memorial Health Care System, 801 N Flamingo Road, Pembroke Pines, FL 33028, FL, USA.
Rolfo C; Florida International University (FIU), 11200 SW 8 St, Miami, FL 33199, FL, USA.

Lung Cancer Manag ; 5(1): 1-4, 2016 Apr.

Article in En | MEDLINE | ID: mdl-30643543

Key words

NTRK inhibitors; TRK1-TRK2-TRK3 fusions; lung cancer; targeted therapy

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Lung Cancer Manag Year: 2016 Document type: Article Affiliation country: United States Country of publication: United kingdom

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Lung Cancer Manag Year: 2016 Document type: Article Affiliation country: United States Country of publication: United kingdom